Patents by Inventor Kristina Stenvall

Kristina Stenvall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hydantoin derivatives for the treatment of obstructive airway diseases
    Patent number: 7989620
    Abstract: The invention provides compounds of formula (I), wherein R1 and R2 are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy.
    Type: Grant
    Filed: December 2, 2009
    Date of Patent: August 2, 2011
    Assignee: AstraZeneca AB
    Inventors: Balint Gabos, Lena Ripa, Kristina Stenvall
  • Novel Hydantoin Derivatives for the Treatment of Obstructive Airway Diseases
    Publication number: 20100144771
    Abstract: The invention provides compounds of formula (I): wherein R1 and R2 are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy.
    Type: Application
    Filed: December 2, 2009
    Publication date: June 10, 2010
    Inventors: Balint Gabos, Lena Ripa, Kristina Stenvall
  • Hydantoin derivatives for the treatment of obstructive airway diseases
    Patent number: 7648992
    Abstract: The invention provides compounds of formula (I), wherein R1 and R2 are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy.
    Type: Grant
    Filed: July 4, 2005
    Date of Patent: January 19, 2010
    Assignee: AstraZeneca AB
    Inventors: Balint Gabos, Lena Ripa, Kristina Stenvall
  • Novel Hydantoin Derivatives for the Treatment of Obstructive Airway Diseases
    Publication number: 20080064710
    Abstract: The invention provides compounds of formula (I), wherein R1 and R2 are as defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy.
    Type: Application
    Filed: July 4, 2005
    Publication date: March 13, 2008
    Applicant: AstraZeneca AB
    Inventors: Balint Gabos, Lena Ripa, Kristina Stenvall
  • Metalloproteinase inhibitors
    Patent number: 7132434
    Abstract: Compounds of the formula (I), useful as metal-loproteinase inhibitors, especially as inhibitors of MMP12
    Type: Grant
    Filed: November 6, 2002
    Date of Patent: November 7, 2006
    Assignee: AstraZeneca AB
    Inventors: Anders Eriksson, Matti Lepistö, Michael Lundkvist, Magnus Munck Af Rosenschöld, Kristina Stenvall, Pavol Zlatoidsky
  • Novel metalloproteinase ihibitors
    Publication number: 20050026990
    Abstract: Compounds of the formula (I), useful as metal-loproteinase inhibitors, especially as inhibitors of MMP12.
    Type: Application
    Filed: November 6, 2002
    Publication date: February 3, 2005
    Inventors: Anders Eriksson, Matti Lepisto, Michael Lundkvist, Magnus Munck Af Rosenschold, Kristina Stenvall, Pavol Zlatoidsky